Sign up to save your podcasts
Or
Share Understanding Blood-Based Biomarkers in Alzheimer Disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
View all episodes
By American Academy of Neurology
4.7
272272 ratings
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.
Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.
Disclosures can be found at Neurology.org.
More shows like Neurology® Podcast
View all
JAMA Editors' Summary
129 Listeners
NEJM This Week
314 Listeners
Practical Neurology Podcast
34 Listeners
JAMA Clinical Reviews
481 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
JAMA Neurology Author Interviews
14 Listeners
Core IM | Internal Medicine Podcast
1,096 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
180 Listeners
The Clinical Problem Solvers
510 Listeners
Neurology Minute
131 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
320 Listeners
Neurology Exam Prep Podcast
178 Listeners
The Curious Clinicians
362 Listeners
Continuum Audio
73 Listeners